Evaluation of MYC and chromosome 8 copy number in breast carcinoma by interphase cytogenetics

Genes Chromosomes and Cancer

Volumn 18, Issue 1, 1997, Pages 1-7

  Visscher, Daniel W ^a,b   Wallis, Tracie ^a,b   Awussah, Solomon ^a,b   Mohamed, Anwar ^a,b   Crissman, John D ^a,b  

^a HARPER UNIVERSITY HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ANEUPLOIDY; ARTICLE; BREAST CARCINOMA; CELL PROLIFERATION; CHROMOSOME 8; CYSTOSARCOMA PHYLLOIDES; CYTOGENETICS; DNA SEQUENCE; FLOW CYTOMETRY; GENE DUPLICATION; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; INTERPHASE; PRIORITY JOURNAL;

ANEUPLOIDY; BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 8; DNA, NEOPLASM; FLOW CYTOMETRY; GENE AMPLIFICATION; GENES, MYC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; PHYLLODES TUMOR; PLOIDIES;

EID: 0031022783     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199701)18:1<1::AID-GCC1>3.0.CO;2-7     Document Type: Article

References (12)

1. Berns EM, Klijn JG, van Putten WL, van Staveren IL, Portengen H, Foekens JA (1992) c-myc Amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer. Cancer Res 1:1107-1113.
2. Bonilla M, Ramirez M, Lopez-Cueto J, Gariglio P (1988) In vivo amplification and rearrangement of c-myc oocogerse in human beast tumors. J Natl Cancer Inst 80:665-671.
3. Escot C, Theillet C, Lidereau R, Spyratos F, Champeme MH, Gest J, Callahan R (1986) Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas. Proc Natl Acad Sci USA 83:4834-4838.
4. Fontana X, Ferrari P, Milano G, Abbes M, Monticelli J, Namer M, Bussiere (1994) Analysis of c-myc amplification by the differential polymerase chain reaction (d-PCR), study in breast cancer. Oncol Reports 1:311-366.
5. Geleick D, Müller H, Mattet A, Torhorst J, Regenass U (1990) Cytogenetics of breast cancer. Cancer Genet Cytogenet 46:217-229.
6. Hopman AH, Voorter CE, Ramacker FC (1994) Detection of genomic changes in cancer by in situ hybridization. Biol Reports 19:31-44.
7. Kreipe H, Feist H, Fischer L, Felner j, Heidorn K, Mettler L, Parwaresch R (1993) Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer. Cancer Res 53:1956-1961.
8. Meyers SL, O'Brien MT, Smith T, Dudley JP (1990) Analysis of the int-1, int-2, c-myc, and neu oncogenes in human breast carcinomas. Cancer Res 50:5911-5918.
9. Pavelic ZP, Pavelic K, Carter C, Pavelic L (1993) Heterogeneity of c-myc expression in histoiogically similar infiltrating ductal carcinomas of the breast. J Cancer Res Clin Oncol 118:16-22.
10. Pertschuk LP, Feldman JG, Kim DS, Nayeri K, Eisenberg KB, Carter AC, Thelmo WT, Rhong ZT, Benn P, Grossman A (1993) Steroid hormone receptor immunohistochemistry and amplification of c-myc protooncogene. Cancer 71:162-171.
11. Tsuda H, Hirohashi S, Hirota T, Shimosato Y (1991) Alterations in copy number of c-erbB-2 and c-myc, proto-oncogencs in advanced stage of human breast cancer. Acta Pathol Jpn 41:19-23.
12. Visscher DW, Zarbo RJ, Jacohsen G, Kambouris A, Talpos G, Sakr W, Crissman JD (1990) Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry. Lab Invest 62:370-378.